{"filing":{"accession_number":"0001193125-26-275086","cik":"0000860730","ticker":"HCA","company_name":"HCA Healthcare, Inc.","form":"8-K","filing_date":"2026-06-18","report_date":null,"primary_document":"d163825d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526275086/d163825d8k.htm"},"events":[{"id":11731,"run_id":10312,"accession_number":"0001193125-26-275086","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Dr. Michael Cuffe, Executive Vice President and Chief Clinical Officer, is stepping down effective August 31, 2026, with a transitional role through February 2027. This is a departure of a named executive officer from a senior leadership position. While severance benefits are mentioned, the principal disclosed action is the departure itself, making this an exec_departure event rather than exec_compensation.","company_name":"HCA Healthcare, Inc.","ticker":"HCA","filing_date":"2026-06-18","form":"8-K","submitted_at":null,"items":[{"id":8393,"accession_number":"0001193125-26-275086","item_number":"5.02","item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Dr. Michael Cuffe, Executive Vice President and Chief Clinical Officer, is stepping down effective August 31, 2026, with a transitional role through February 2027. This is a departure of a named executive officer from a senior leadership position. While severance benefits are mentioned, the principal disclosed action is the departure itself, making this an exec_departure event rather than exec_compensation.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T13:13:06.203840+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8393,"accession_number":"0001193125-26-275086","item_number":"5.02","item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Dr. Michael Cuffe, Executive Vice President and Chief Clinical Officer, is stepping down effective August 31, 2026, with a transitional role through February 2027. This is a departure of a named executive officer from a senior leadership position. While severance benefits are mentioned, the principal disclosed action is the departure itself, making this an exec_departure event rather than exec_compensation.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T13:13:06.203840+00:00","company_name":"HCA Healthcare, Inc.","ticker":"HCA","filing_date":"2026-06-18"}]}